Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cerri

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Chest|June 9, 2019
Do Not Forget to Assess the Muscle Integrity in Patients With COPDStefania Cerri, Enrico Clini
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?Fabrizio Luppi, Stefania Cerri, Luca Richeldi
Expert Opinion on Emerging Drugs|March 18, 2011
Emerging drugs for idiopathic pulmonary fibrosisMoisés Selman, Annie Pardo, Luca Richeldi, et al.
Journal of Medical Case Reports|July 9, 2016
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case reportStefania Cerri, Giacomo Sgalla, Luca Richeldi, et al.
Current Opinion in Pulmonary Medicine|July 5, 2012
The big clinical trials in idiopathic pulmonary fibrosisFabrizio Luppi, Paolo Spagnolo, Stefania Cerri, et al.
Orphanet Journal of Rare Diseases|October 19, 2012
Genetic testing in diffuse parenchymal lung diseasePaolo Spagnolo, Fabrizio Luppi, Stefania Cerri, et al.
Clinics in Chest Medicine|February 28, 2012
Management of idiopathic pulmonary fibrosisStefania Cerri, Paolo Spagnolo, Fabrizio Luppi, et al.
International Journal of Molecular Sciences|September 10, 2021
COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk FactorsBianca Beghé, Stefania Cerri, Leonardo M Fabbri, et al.
Internal and Emergency Medicine|February 13, 2015
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical reviewFabrizio Luppi, Stefania Cerri, Sofia Taddei, et al.
Case Reports in Medicine|April 2, 2020
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung DiseaseCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Chest|June 9, 2019
Do Not Forget to Assess the Muscle Integrity in Patients With COPDStefania Cerri, Enrico Clini
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 7, 2006
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?Fabrizio Luppi, Stefania Cerri, Luca Richeldi
Expert Opinion on Emerging Drugs|March 18, 2011
Emerging drugs for idiopathic pulmonary fibrosisMoisés Selman, Annie Pardo, Luca Richeldi, et al.
Journal of Medical Case Reports|July 9, 2016
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case reportStefania Cerri, Giacomo Sgalla, Luca Richeldi, et al.
Current Opinion in Pulmonary Medicine|July 5, 2012
The big clinical trials in idiopathic pulmonary fibrosisFabrizio Luppi, Paolo Spagnolo, Stefania Cerri, et al.
Orphanet Journal of Rare Diseases|October 19, 2012
Genetic testing in diffuse parenchymal lung diseasePaolo Spagnolo, Fabrizio Luppi, Stefania Cerri, et al.
Clinics in Chest Medicine|February 28, 2012
Management of idiopathic pulmonary fibrosisStefania Cerri, Paolo Spagnolo, Fabrizio Luppi, et al.
International Journal of Molecular Sciences|September 10, 2021
COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk FactorsBianca Beghé, Stefania Cerri, Leonardo M Fabbri, et al.
Internal and Emergency Medicine|February 13, 2015
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical reviewFabrizio Luppi, Stefania Cerri, Sofia Taddei, et al.
Case Reports in Medicine|April 2, 2020
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung DiseaseCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Pageof 10